中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Show More
2014
Ascletis and CR Pharmaceutical Commercial Group Co., Ltd. Signed Strategic Cooperation Agreement
2018-06-26
Ascletis Receives NDA Approval from China FDA for Ganovo®
2018-06-13
Dr. Vivian Chen，Former VP of Eli Lilly China,Joined Ascletis as VP, Corporate Affairs
2018-03-19
Ascletis Presented at J.P. Morgan Healthcare Conference
2018-01-10
Populations of data propel China to the forefront of biotech
2018-01-05
«
1
2
浙公网安备 33010802003344号
浙ICP备11050387号-1